Subcutaneous interferon β-1a three times weekly and the natural evolution of gadolinium-enhancing lesions into chronic black holes in relapsing and progressive multiple sclerosis: Analysis of PRISMS and SPECTRIMS trials

Eitemau Tebyg

• Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis()
  gan: Tam, Roger C., et al.
  Cyhoeddwyd: (2012)
• Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1
  gan: Traboulsee, Anthony, et al.
  Cyhoeddwyd: (2018)
• Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study
  gan: Traboulsee, Anthony, et al.
  Cyhoeddwyd: (2018)
• Gadolinium Deposition in Deep Brain Structures: Relationship with Dose and Ionization of Linear Gadolinium-Based Contrast Agents
  gan: Kang, H., et al.
  Cyhoeddwyd: (2018)
• Interferon β-1a subcutaneously 3 times/week clinical outcome in relapsing multiple sclerosis in Finland
  gan: Järvinen, Elina, et al.
  Cyhoeddwyd: (2019)